查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1872099

左心室輔助裝置（LVAD）－全球市佔率和排名、總收入和需求預測（2025-2031年）

Left Ventricular Assist Device (LVAD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 102 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球左心室輔助裝置（LVAD）市場在2024年達到 18.45億美元，預計到2031年將達到 34.95億美元，2025年至2031年的年複合成長率為 9.2%。

本報告全面評估了左心室輔助裝置（LVAD）的跨境產業佈局、資本配置模式、區域經濟相互依存關係，以及近期針對供應鏈重組的關稅調整和國際戰略應對措施。

左心室輔助裝置（LVAD）是一種透過外科手術植入的機械循環支援裝置，可以幫助左心室將血液泵送到全身。它主要用於等待心臟移植的晚期心臟衰竭患者（移植過渡治療）、仿單標示外移植的患者（根治性治療）或需要臨時支持以促進心臟功能恢復的患者（恢復過渡治療）。 LVAD由幫浦、驅動線、外部控制器和電源組成，可顯著提高重度心臟衰竭患者的生存率和生活品質。

左心室輔助裝置（LVAD）市場的主要驅動力是進行性心臟衰竭盛行率的不斷上升以及等待心臟移植或不符合移植條件的患者人數的增加。 LVAD技術的進步，例如小型化泵、連續流系統和更長的電池壽命，顯著提高了裝置性能，降低了併發症率，並改善了患者的生存率和生活品質。此外，臨床醫師和病患對LVAD的認知不斷提高，以及已開發國家有利的醫保償付政策，正促使LVAD作為長期治療方案得到更廣泛的應用。

儘管左心室輔助裝置（LVAD）具有許多臨床優勢，但其市場仍面臨許多挑戰。其中包括高昂的植入和維護成本，這限制了中低收入國家的普及。感染疾病、血栓症、出血和裝置故障等嚴重併發症的風險仍然是患者和醫療服務提供者都非常關注的問題。此外，終身裝置管理、對外部電源的依賴以及複雜的術後護理都會影響患者的依從性和治療效果。監管障礙和專業手術中心數量有限也阻礙了LVAD的廣泛應用。

本報告目的是對全球左心室輔助裝置（LVAD）市場進行全面分析，重點關注總銷售量、收入、價格、企業市場占有率和主要企業的排名，並依地區/國家、類型和應用對左心室輔助裝置（LVAD）進行分析。

本報告以數量（單位）和收入（百萬美元）為單位，提供左心室輔助裝置（LVAD）市場規模、估計值和預測，基準年為2024年，並包含2020年至2031年的歷史資料和預測資料。定量和定性分析將幫助讀者制定左心室輔助裝置（LVAD）的業務和成長策略，評估市場競爭，分析自身在當前市場中的地位，並做出明智的商業決策。

市場區隔

公司

  • AbioMed
  • Abbott（Thoratec）
  • Medtronic（HeartWare）
  • Berlin Heart
  • Jarvik Heart
  • Sun Medical Technology Research
  • ReliantHeart
  • CH Biomedical

依類型

  • BTT療法
  • 目的地療法（DT）
  • 其他

依應用

  • 醫院
  • 診所

依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for Left Ventricular Assist Device (LVAD) was estimated to be worth US$ 1845 million in 2024 and is forecast to a readjusted size of US$ 3495 million by 2031 with a CAGR of 9.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Left Ventricular Assist Device (LVAD) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

A Left Ventricular Assist Device (LVAD) is a mechanical circulatory support device that is surgically implanted to help the left ventricle pump blood to the rest of the body. It is primarily used in patients with advanced heart failure who are awaiting heart transplantation (bridge-to-transplant), not eligible for transplant (destination therapy), or need temporary support for heart recovery (bridge-to-recovery). The LVAD consists of a pump, a driveline, and an external controller and power source, and can significantly improve survival and quality of life in patients with severe cardiac dysfunction.

The Left Ventricular Assist Device (LVAD) market is primarily driven by the increasing prevalence of advanced heart failure and the growing number of patients who are either awaiting heart transplantation or are ineligible for transplant. Advances in LVAD technology-such as miniaturized pumps, continuous-flow systems, and improved battery life-have significantly enhanced device performance, reduced complication rates, and improved patient survival and quality of life. Additionally, expanding awareness among clinicians and patients, as well as favorable reimbursement policies in developed countries, are contributing to broader adoption of LVADs as a viable long-term treatment option.

Despite its clinical benefits, the LVAD market faces several challenges, including high costs of implantation and maintenance, which limit access in low- and middle-income countries. The risk of serious complications-such as infection, thrombosis, bleeding, and device malfunction-remains a significant concern for both patients and providers. Moreover, the need for lifelong device management, dependence on external power sources, and the complexity of post-operative care can affect patient adherence and outcomes. Regulatory hurdles and limited availability of specialized surgical centers also pose barriers to wider adoption.

This report aims to provide a comprehensive presentation of the global market for Left Ventricular Assist Device (LVAD), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Left Ventricular Assist Device (LVAD) by region & country, by Type, and by Application.

The Left Ventricular Assist Device (LVAD) market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Left Ventricular Assist Device (LVAD).

Market Segmentation

By Company

  • AbioMed
  • Abbott (Thoratec)
  • Medtronic (HeartWare)
  • Berlin Heart
  • Jarvik Heart
  • Sun Medical Technology Research
  • ReliantHeart
  • CH Biomedical

Segment by Type

  • BTT Therapy
  • Destination Therapy (DT)
  • Other

Segment by Application

  • Hospitals
  • Clinics

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Left Ventricular Assist Device (LVAD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Left Ventricular Assist Device (LVAD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Left Ventricular Assist Device (LVAD) in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Left Ventricular Assist Device (LVAD) Product Introduction
  • 1.2 Global Left Ventricular Assist Device (LVAD) Market Size Forecast
    • 1.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value (2020-2031)
    • 1.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume (2020-2031)
    • 1.2.3 Global Left Ventricular Assist Device (LVAD) Sales Price (2020-2031)
  • 1.3 Left Ventricular Assist Device (LVAD) Market Trends & Drivers
    • 1.3.1 Left Ventricular Assist Device (LVAD) Industry Trends
    • 1.3.2 Left Ventricular Assist Device (LVAD) Market Drivers & Opportunity
    • 1.3.3 Left Ventricular Assist Device (LVAD) Market Challenges
    • 1.3.4 Left Ventricular Assist Device (LVAD) Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Left Ventricular Assist Device (LVAD) Players Revenue Ranking (2024)
  • 2.2 Global Left Ventricular Assist Device (LVAD) Revenue by Company (2020-2025)
  • 2.3 Global Left Ventricular Assist Device (LVAD) Players Sales Volume Ranking (2024)
  • 2.4 Global Left Ventricular Assist Device (LVAD) Sales Volume by Company Players (2020-2025)
  • 2.5 Global Left Ventricular Assist Device (LVAD) Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Left Ventricular Assist Device (LVAD) Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Left Ventricular Assist Device (LVAD) Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Left Ventricular Assist Device (LVAD)
  • 2.9 Left Ventricular Assist Device (LVAD) Market Competitive Analysis
    • 2.9.1 Left Ventricular Assist Device (LVAD) Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Left Ventricular Assist Device (LVAD) Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left Ventricular Assist Device (LVAD) as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 BTT Therapy
    • 3.1.2 Destination Therapy (DT)
    • 3.1.3 Other
  • 3.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Type
    • 3.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Left Ventricular Assist Device (LVAD) Sales Value, by Type (2020-2031)
    • 3.2.3 Global Left Ventricular Assist Device (LVAD) Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type
    • 3.3.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Left Ventricular Assist Device (LVAD) Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospitals
    • 4.1.2 Clinics
  • 4.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Application
    • 4.2.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Left Ventricular Assist Device (LVAD) Sales Value, by Application (2020-2031)
    • 4.2.3 Global Left Ventricular Assist Device (LVAD) Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application
    • 4.3.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Left Ventricular Assist Device (LVAD) Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Left Ventricular Assist Device (LVAD) Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Region
    • 5.1.1 Global Left Ventricular Assist Device (LVAD) Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2020-2025)
    • 5.1.3 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2026-2031)
    • 5.1.4 Global Left Ventricular Assist Device (LVAD) Sales Value by Region (%), (2020-2031)
  • 5.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region
    • 5.2.1 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2020-2025)
    • 5.2.3 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2026-2031)
    • 5.2.4 Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Left Ventricular Assist Device (LVAD) Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.4.2 North America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.5.2 Europe Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.7.2 South America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.3.2 United States Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.4.2 Europe Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.5.2 China Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.6.2 Japan Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.7.2 South Korea Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Left Ventricular Assist Device (LVAD) Sales Value, 2020-2031
    • 6.9.2 India Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Left Ventricular Assist Device (LVAD) Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 AbioMed
    • 7.1.1 AbioMed Company Information
    • 7.1.2 AbioMed Introduction and Business Overview
    • 7.1.3 AbioMed Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 AbioMed Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.1.5 AbioMed Recent Development
  • 7.2 Abbott (Thoratec)
    • 7.2.1 Abbott (Thoratec) Company Information
    • 7.2.2 Abbott (Thoratec) Introduction and Business Overview
    • 7.2.3 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.2.5 Abbott (Thoratec) Recent Development
  • 7.3 Medtronic (HeartWare)
    • 7.3.1 Medtronic (HeartWare) Company Information
    • 7.3.2 Medtronic (HeartWare) Introduction and Business Overview
    • 7.3.3 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.3.5 Medtronic (HeartWare) Recent Development
  • 7.4 Berlin Heart
    • 7.4.1 Berlin Heart Company Information
    • 7.4.2 Berlin Heart Introduction and Business Overview
    • 7.4.3 Berlin Heart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Berlin Heart Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.4.5 Berlin Heart Recent Development
  • 7.5 Jarvik Heart
    • 7.5.1 Jarvik Heart Company Information
    • 7.5.2 Jarvik Heart Introduction and Business Overview
    • 7.5.3 Jarvik Heart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Jarvik Heart Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.5.5 Jarvik Heart Recent Development
  • 7.6 Sun Medical Technology Research
    • 7.6.1 Sun Medical Technology Research Company Information
    • 7.6.2 Sun Medical Technology Research Introduction and Business Overview
    • 7.6.3 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.6.5 Sun Medical Technology Research Recent Development
  • 7.7 ReliantHeart
    • 7.7.1 ReliantHeart Company Information
    • 7.7.2 ReliantHeart Introduction and Business Overview
    • 7.7.3 ReliantHeart Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 ReliantHeart Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.7.5 ReliantHeart Recent Development
  • 7.8 CH Biomedical
    • 7.8.1 CH Biomedical Company Information
    • 7.8.2 CH Biomedical Introduction and Business Overview
    • 7.8.3 CH Biomedical Left Ventricular Assist Device (LVAD) Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 CH Biomedical Left Ventricular Assist Device (LVAD) Product Offerings
    • 7.8.5 CH Biomedical Recent Development

8 Industry Chain Analysis

  • 8.1 Left Ventricular Assist Device (LVAD) Industrial Chain
  • 8.2 Left Ventricular Assist Device (LVAD) Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Left Ventricular Assist Device (LVAD) Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Left Ventricular Assist Device (LVAD) Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Left Ventricular Assist Device (LVAD) Market Trends
  • Table 2. Left Ventricular Assist Device (LVAD) Market Drivers & Opportunity
  • Table 3. Left Ventricular Assist Device (LVAD) Market Challenges
  • Table 4. Left Ventricular Assist Device (LVAD) Market Restraints
  • Table 5. Global Left Ventricular Assist Device (LVAD) Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Left Ventricular Assist Device (LVAD) Revenue Market Share by Company (2020-2025)
  • Table 7. Global Left Ventricular Assist Device (LVAD) Sales Volume by Company (2020-2025) & (Units)
  • Table 8. Global Left Ventricular Assist Device (LVAD) Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Left Ventricular Assist Device (LVAD) Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Left Ventricular Assist Device (LVAD) Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Left Ventricular Assist Device (LVAD) Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Left Ventricular Assist Device (LVAD)
  • Table 13. Global Left Ventricular Assist Device (LVAD) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Left Ventricular Assist Device (LVAD) as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Left Ventricular Assist Device (LVAD) Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
  • Table 22. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2020-2025) & (Units)
  • Table 23. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2026-2031) & (Units)
  • Table 24. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Left Ventricular Assist Device (LVAD) Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Left Ventricular Assist Device (LVAD) Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Left Ventricular Assist Device (LVAD) Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
  • Table 34. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2020-2025) & (Units)
  • Table 35. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2026-2031) & (Units)
  • Table 36. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Left Ventricular Assist Device (LVAD) Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Left Ventricular Assist Device (LVAD) Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Left Ventricular Assist Device (LVAD) Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Left Ventricular Assist Device (LVAD) Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Left Ventricular Assist Device (LVAD) Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (Units): 2020 VS 2024 VS 2031
  • Table 46. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2020-2025) & (Units)
  • Table 47. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2026-2031) & (Units)
  • Table 48. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Left Ventricular Assist Device (LVAD) Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Left Ventricular Assist Device (LVAD) Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Left Ventricular Assist Device (LVAD) Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume, (2020-2025) & (Units)
  • Table 56. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume, (2026-2031) & (Units)
  • Table 57. AbioMed Company Information
  • Table 58. AbioMed Introduction and Business Overview
  • Table 59. AbioMed Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. AbioMed Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 61. AbioMed Recent Development
  • Table 62. Abbott (Thoratec) Company Information
  • Table 63. Abbott (Thoratec) Introduction and Business Overview
  • Table 64. Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Abbott (Thoratec) Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 66. Abbott (Thoratec) Recent Development
  • Table 67. Medtronic (HeartWare) Company Information
  • Table 68. Medtronic (HeartWare) Introduction and Business Overview
  • Table 69. Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Medtronic (HeartWare) Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 71. Medtronic (HeartWare) Recent Development
  • Table 72. Berlin Heart Company Information
  • Table 73. Berlin Heart Introduction and Business Overview
  • Table 74. Berlin Heart Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Berlin Heart Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 76. Berlin Heart Recent Development
  • Table 77. Jarvik Heart Company Information
  • Table 78. Jarvik Heart Introduction and Business Overview
  • Table 79. Jarvik Heart Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Jarvik Heart Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 81. Jarvik Heart Recent Development
  • Table 82. Sun Medical Technology Research Company Information
  • Table 83. Sun Medical Technology Research Introduction and Business Overview
  • Table 84. Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Sun Medical Technology Research Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 86. Sun Medical Technology Research Recent Development
  • Table 87. ReliantHeart Company Information
  • Table 88. ReliantHeart Introduction and Business Overview
  • Table 89. ReliantHeart Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. ReliantHeart Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 91. ReliantHeart Recent Development
  • Table 92. CH Biomedical Company Information
  • Table 93. CH Biomedical Introduction and Business Overview
  • Table 94. CH Biomedical Left Ventricular Assist Device (LVAD) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. CH Biomedical Left Ventricular Assist Device (LVAD) Product Offerings
  • Table 96. CH Biomedical Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Left Ventricular Assist Device (LVAD) Downstream Customers
  • Table 100. Left Ventricular Assist Device (LVAD) Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Left Ventricular Assist Device (LVAD) Product Picture
  • Figure 2. Global Left Ventricular Assist Device (LVAD) Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Left Ventricular Assist Device (LVAD) Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Left Ventricular Assist Device (LVAD) Sales Volume (2020-2031) & (Units)
  • Figure 5. Global Left Ventricular Assist Device (LVAD) Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Left Ventricular Assist Device (LVAD) Report Years Considered
  • Figure 7. Global Left Ventricular Assist Device (LVAD) Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Left Ventricular Assist Device (LVAD) Players Sales Volume Ranking (2024) & (Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Left Ventricular Assist Device (LVAD) Revenue in 2024
  • Figure 10. Left Ventricular Assist Device (LVAD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. BTT Therapy Picture
  • Figure 12. Destination Therapy (DT) Picture
  • Figure 13. Other Picture
  • Figure 14. Global Left Ventricular Assist Device (LVAD) Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 15. Global Left Ventricular Assist Device (LVAD) Sales Value Market Share by Type, 2024 & 2031
  • Figure 16. Global Left Ventricular Assist Device (LVAD) Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
  • Figure 17. Global Left Ventricular Assist Device (LVAD) Sales Volume Market Share by Type, 2024 & 2031
  • Figure 18. Global Left Ventricular Assist Device (LVAD) Price by Type (2020-2031) & (US$/Unit)
  • Figure 19. Product Picture of Hospitals
  • Figure 20. Product Picture of Clinics
  • Figure 21. Global Left Ventricular Assist Device (LVAD) Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Left Ventricular Assist Device (LVAD) Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Left Ventricular Assist Device (LVAD) Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
  • Figure 24. Global Left Ventricular Assist Device (LVAD) Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Left Ventricular Assist Device (LVAD) Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Left Ventricular Assist Device (LVAD) Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Left Ventricular Assist Device (LVAD) Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Left Ventricular Assist Device (LVAD) Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Left Ventricular Assist Device (LVAD) Sales Volume (%), (2020-2031)
  • Figure 38. United States Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Left Ventricular Assist Device (LVAD) Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Left Ventricular Assist Device (LVAD) Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Left Ventricular Assist Device (LVAD) Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Left Ventricular Assist Device (LVAD) Industrial Chain
  • Figure 60. Left Ventricular Assist Device (LVAD) Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed